Tocilizumab in sarcoidosis patients failing steroid sparing therapies and anti-TNF agents.
Respiratory Medicine: X（2019）
摘要
•Tocilizumab may represent a novel therapy in patients with sarcoidosis.•Our hypothesis is IL6 receptor inhibition blocks sarcoidosis granuloma formation.•Formal clinical trials of IL6 inhibitory therapies should be considered.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要